Pharmaceutical Technology site between 18 June and 01 July. The poll findings are in line with those of another poll conducted by Verdict earlier in April, which found high confidence about the possible development of a COVID-19 vaccine within 12 months.
Research organisations and pharmaceutical companies have joined hands in developing a vaccine against the COVID-19 virus that has affected millions of people.
Existing drugs such as remdesivir have been granted emergency use authorisation (EUA) to treat the disease, meanwhile. Antimalarial drugs including chloroquine and hydroxychloroquine were also awarded EUA, but later revoked after studies showed that they were ineffective in treating the disease.